Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T3-release from autonomously functioning thyroid nodules in vitro.

S Poertl1, J Kirner, B Saller

  • 1Department of Medicine, University of Essen, Germany. stefan.poertl@uni-essen.de

Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|March 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly.

European journal of endocrinology·2009
Same author

From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis.

European journal of endocrinology·2009
Same author

The German ACROSTUDY: past and present.

European journal of endocrinology·2009
Same author

Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study.

European journal of endocrinology·2009
Same author

Diagnosing neuroendocrine dysfunction in patients after aneurysmal subarachnoid hemorrhage in clinical practice - does basal hormone screening make sense?

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2008
Same author

High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels.

Clinical endocrinology·2008
Same journal

Association of Fibroblast Growth Factor 21 with Excessive Intrapancreatic Fat Deposition in Type 2 Diabetes Mellitus.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same journal

Mild cognitive impairment in newly diagnosed type 2 diabetes without microvascular or macrovascular complications: Prevalence, dynamics, and clinical predictors.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same journal

Cardiovascular Disease Risk Knowledge and Lifestyle Behaviors Among Adults With Metabolic Syndrome: A Cross Sectional Study.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same journal

Comparative Efficacy of Oral Antidiabetic Drugs on Metabolic Dysfunction-Associated Steatotic Liver Disease (MΑSLD) Progression in Type 2 Diabetes: A Retrospective Cohort Study.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same journal

Nutritional Recommendations for the Prevention of Type 2 Diabetes Mellitus.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same journal

Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score and Diabetic Neuropathy in Patients with Type 2 Diabetes Mellitus.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
See all related articles

Toxic thyroid nodules show higher basal hormone release than normal tissues. This enhanced activity may be due to genetic mutations and can be further stimulated by TSH or antibodies.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Toxic thyroid nodules are of clonal origin.
  • Mutations in TSH receptor (TSHr) or G-protein alpha-subunit genes cause enhanced cAMP levels, potentially increasing thyrocyte activity.
  • Previous studies identified these mutations in some toxic nodules.

Purpose of the Study:

  • To compare in vitro hormone (T3) release from toxic thyroid nodules with surrounding tissues, euthyroid goiter, and Graves' disease tissues.
  • To investigate the effects of bovine TSH (bTSH) and Graves' immunoglobulins on T3 release.
  • To explore the role of genetic mutations in the hyperfunction of toxic thyroid nodules.

Main Methods:

  • Surgical tissue samples from toxic nodules, paranodular tissue, euthyroid goiter, and Graves' disease were incubated.

Related Experiment Videos

  • Tissues were stimulated with bTSH or Graves' sera.
  • Free T3 levels were measured using radioimmunoassay (RIA) after incubation and equilibrium dialysis.

    • Main Results:

    • Basal T3 release was significantly higher in toxic nodular tissues compared to all other tested tissues.
    • bTSH stimulation increased T3 release in nodular, paranodular, and euthyroid goiter tissues, but not significantly in Graves' disease tissues.
    • Graves' sera stimulated basal hormone release in 75% of toxic nodular tissues, suggesting a role for TSH receptor antibodies.

    Conclusions:

    • Toxic thyroid nodules exhibit enhanced basal T3 release in vitro, likely due to constitutive activation of TSHr or G-protein signaling pathways via gene mutations.
    • External factors like TSH and TSH receptor antibodies can further exacerbate hyperfunction in toxic nodules.
    • These findings have clinical implications for managing toxic nodules, especially in patients with unsuppressed TSH or rare conditions like Marine Lenhart syndrome.